United Therapeutics Corp

Common Name

United Therapeutics

Country

United States

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1,305

Ticker

UTHR

Exchange

NASDAQ/NGS

Website

www.unither.com

Description

United Therapeutics Corporation is a biotechnology company engaged in the development and commercialization of innovative pharmaceutical products. Primarily focusing on therapies to address unmet medi... Show more

Financial Statements of United Therapeutics

Below are the financial statements of United Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	1,697.2^a	1,207.7^a
Marketable investments	1,569.8^a	1,786.4^a
Accounts receivable, no allowance for 2024 and 2023	279.3^a	278.9^a
Inventories, net	157.9^a	111.8^a
Other current assets	169.7^a	166.2^a
Total current assets	3,873.9^a	3,551^a
Assets	—	—
Marketable investments	1,475.3^a	1,909.8^a
Goodwill and other intangible assets, net	111.9^a	114.2^a
Property, plant, and equipment, net	1,222.4^a	1,045.4^a
Deferred tax assets, net	458.4^a	394.8^a
Other non-current assets	222.1^a	151.8^a
Total assets	7,364^a	7,167^a
Current liabilities	—	—
Accounts payable and accrued expenses	344.5^a	298^a
Line of credit (current)	300^a	400^a
Share tracking awards plan	11^a	35.4^a
Other current liabilities	82.6^a	71^a
Total current liabilities	738.1^a	804.4^a
Liabilities and stockholders’ equity	—	—
Line of credit (non-current)	0^a	300^a
Other non-current liabilities	181.9^a	77.8^a
Total liabilities	920^a	1,182.2^a
Stockholders’ equity	—	—
Preferred stock	0^a	0^a
Common stock	0.8^a	0.7^a
Additional paid-in capital	2,698.9^a	2,549^a
Accumulated other comprehensive loss	-3.4^a	-12.8^a
Treasury stock	-3,474.5^a	-2,579.2^a
Retained earnings	7,222.2^a	6,027.1^a
Total stockholders’ equity	6,444^a	5,984.8^a
Total liabilities and stockholders’ equity	7,364^a	7,167^a

Verified Sources Behind United Therapeutics’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore United Therapeutics’s data sources below and access millions more through our Disclosure Search.

a. United Therapeutics's 10-K 2024

Trace every data point back to United Therapeutics’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

United Therapeutics Corp

Financial Statements of United Therapeutics

Verified Sources Behind United Therapeutics’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Neurocrine Biosciences Inc

Viatris Inc

Zoetis Inc

BioMarin Pharmaceutical Inc

Dexcom Inc

Zimmer Biomet Holdings Inc